A clinical trial has found that fluvoxamine, a selective serotonin reuptake inhibitor (SSRI) antidepressant, significantly reduces the chances of hospitalization
COVID-19: Antidepressant reduces risk of hospitalization and death

besthealthtale.com
Home ยป
A clinical trial has found that fluvoxamine, a selective serotonin reuptake inhibitor (SSRI) antidepressant, significantly reduces the chances of hospitalization
Most clinical trials do not score highly on the diversity front. In this Special Feature, we explore who takes part